Released May 8, 2014, before the open
10-Q filed May 8, 2014, 38 days after period end · 0001193125-14-188536
Q1 2014 · 10-Q
Revenue$100.01M$100.01M −2.2% vs Q1 2013−5.5% vs Q4 2013
Net Income-$2.51M-$2.51M N/M vs Q1 2013N/M vs Q4 2013
EPS Diluted-$0.14-$0.14 N/M vs Q1 2013N/M vs Q4 2013
Gross Profit$73,241,000−4.2%
Operating Income-$29,000N/M
Operating Cash Flow-$10,212,000N/M
Free Cash Flowderived-$13,903,000N/M
Margins · derived
Gross margin73.2%−1.5 pt vs Q1 2013
Operating margin-0.0%−6.0 pt vs Q1 2013
Net margin-2.5%−5.9 pt vs Q1 2013
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q1 2014 | Q1 2013 | Q1 2012 | Q1 2011 |
|---|---|---|---|---|
| Revenue | $100.01M | $102.28M | $107.16M | $103.61M |
| Net Income | -$2.51M | $3.45M | $7.35M | -$41.47M |
| EPS Diluted | -$0.14 | $0.18 | $0.38 | -$2.31 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Orthofix Medical Inc. · CIK 884624 · Engraved from SEC EDGAR